11 Biotechnology Law Report 141 (Number 2, March-April 1992)

Canadian government officials say that some changes are already beingmade, including consultations with the U.S. government, as well as within theCanadian government.

Editorial note: The Bush Administration has proposed changes in U.S.biotechnology regulations also. A story on the subject will appear in the nextissue of BLR.

# # #

BLR BIBLIOGRAPHY

{BLR 1295} Directories-

Human Genome Project-

DNA Fingerprinting.

1991 Biotechnology DirectoryThe Biotechnology Directory 1992 by J. Coombs and Y. R. Alston is

available from Stockton Press. The new edition has sections on internationalorganizations and information services; more than 10,000 companies,university and government departments, institutes, and societies; and a buyer'sguide to sources of more than 1,500 products and services. Those who placestanding orders for future editions get a 5% discount.

The Directory (No. 1-56159-023-1) is $215.00 Also available is the secondedition of Biotechnology Guide U.S.A., covering only firms in this country(1-56159-015-0; $199.00). For prepaid orders, add $5.00 S&H for first book,$2.00 for each additional book. In New York and Canada, add appropriatesales tax.

Contact: Stockton Press, 257 Park Ave. South, New York, NY 10010. Tollfree: 1-800-221-2123 (in NY: 212-673-4400); fax 212-673-9842.

NIH Videotape on Human Genome ProjectThe National Center for Human Genome Research has a videotape to inform

the public about the goals of the Human Genome Project and the impact theresearch will have on health care. For information about the tape, titled "TheHuman Genome Project," contact Leslie Fink, Office ofCommunications,National Center for Human Genome Research, Building 38A, Room 617, 9000Rockville Pike, Bethesda, MD 20892.

11 Biotechnology Law Report 142 (Number 2, March-April 1992)

Stanford Human Genome SeminarAvailable on Videotape

A January 1991 Stanford University seminar entitled "The Human GenomeProject: Biological Opportunies and Social Consequences" has become availableon videotape. Among the presentations was one by Mary Claire King,Professor of Epidemiology, University ofCalifornia—Berkeley, who usedgenetic markers on mitochondrial DNA to reunite children with their familites.These children are the offspring of women who were pregnant when they werecaptured as subversives or infants whose families were killed for the samereason. In 1979, the grandmothers ofmissing babies began demanding thereturn of their grandchildren. Because mitochondrial DNA is inherited entirelyfrom the mother, study of a variable section of the molecule permitted Dr. Kingto reunite at least 49 children with their biologic families.The videotapes also include a panel discussion of the ethical, social, and

legal implications of the Human Genome Project. The $325 price covers ninecassettes and a binder of program notes and an overview. Contact StanfordVideo and Electronic Media Group, Bowman Alumni House, Stanford, CA94305-4005 telephone (415) 723-2021.

ON THE MOVE

{BLR 1296} Biotechnology Attorneys and Regulatory Professionals.

ASSOCIATION OF BIOTECHNOLOGY COMPANIESNAMES NEW EXECUTIVE DIRECTOR

The Association of Biotechnology Companies (ABC) has named William E.Small its new Executive Director. Small has served with the American MedicalAssociation, the American Nurses Association, the American PharmaceuticalAssociation, and the American Academy ofOtolaryngology. He also has beenExecutive Director of the National Foundation for Infectious Diseases, a staffmember of the U.S. Senate, head of communications for the National Bureau ofStandards, and a science and technology reporter for McGraw-Hill and ScienceNews.

Small earned a B.S. in geology and an M.A. in communications fromMichigan State Univeristy. He assumed his duties as chief executive officer atABC on February 3.

GIOTTA BECOMES CHIEF INTELLECTUALPROPERTY COUNSEL FOR GLYCOMED

Gregory J. Giotta, J.D., Ph.D., has been appointed Chief IntellectualProperty Counsel ofGlycomed Inc. of Alameda, Cal. He will be responsiblefor all aspects of the company's patents, patent applications, trademarks, andother intellectual property matters. Giotta joins the firm from Cetus, where hewas Director of Patents and Trademarks for Therapeutics. He was involved in